INFLUENCE OF VOJTA THERAPY IN CEREBRAL PALSY. INFANTILE HEMIPARESIS

December 27, 2025 updated by: Centro Integral Kaplan

INFLUENCE OF VOJTA THERAPY ON POSTURAL CONTROL AND MANIPULATION IN CEREBRAL PALSY INFANTILE HEMIPARESIS

This study describes a single pediatric case with hemiparesis who received a specialized physiotherapy intervention based on the Vojta method. The child, aged 15 years, was treated in a clinical setting by a physiotherapist certified in Vojta therapy during one intensive treatment session. Upper limb function was evaluated before and after the intervention using the Box and Block Test, as well as electroencephalography (EEG) and electromyography (EMG) recordings to explore changes in motor control and brain activity. The main purpose of this study is to document the feasibility and short-term effects of a Vojta-based physiotherapy session on upper limb function and neurophysiological parameters in a child with hemiparesis

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This single-case clinical study involves a 15-year-old child with hemiparesis who underwent a physiotherapy intervention using the Vojta method in an outpatient clinic. The intervention consisted of one intensive treatment session delivered by an experienced physiotherapist specialized in Vojta therapy, following standardized stimulation patterns tailored to the patient's motor profile. Upper limb function was assessed immediately before and after the intervention using the Box and Block Test, while simultaneous EEG and EMG recordings were obtained to characterize cortical and muscular activation during motor tasks. The primary objective is to evaluate short-term changes in manual function, and the secondary objective is to describe associated neurophysiological changes, to generate hypotheses for future clinical trials in pediatric patients with hemiparesis.

Study Type

Interventional

Enrollment (Actual)

1

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Madrid, Madrid, Spain, 28850
        • Centro Kaplan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Hemiparesis, 0-16 years, cognitive ability to perform the Box and Block Test

Exclusion Criteria:

  • Severe musculoskeletal deformities or pain in the upper limb that prevent the performance of the Box and Block Test, Severe visual or auditory impairment that prevents understanding or performing the Box and Block Test

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vojta Therapy
One intensive physiotherapy session based on the Vojta method, delivered by a physiotherapist specialized in Vojta therapy in an outpatient clinic
One intensive physiotherapy session based on the Vojta method, including standardized reflex locomotion stimulation patterns, delivered by a physiotherapist specialized in Vojta therapy in an outpatient clinic

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in upper limb manual dexterity (Box and Block Test)
Time Frame: Baseline and immediately after the Vojta therapy session
Manual dexterity of the affected upper limb will be assessed using the Box and Block Test. Higher scores indicate better manual dexterity
Baseline and immediately after the Vojta therapy session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 22, 2024

Primary Completion (Actual)

January 22, 2024

Study Completion (Actual)

January 22, 2024

Study Registration Dates

First Submitted

December 27, 2025

First Submitted That Met QC Criteria

December 27, 2025

First Posted (Estimated)

January 12, 2026

Study Record Updates

Last Update Posted (Estimated)

January 12, 2026

Last Update Submitted That Met QC Criteria

December 27, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because this is a single-case study and the data are potentially identifiable, making it difficult to fully protect the participant's privacy.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric Hemiparesis

Clinical Trials on Vojta therapy session

Subscribe